ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Apart from negative correlations with adiposity measures, studies revealed that adiponectin levels seem to be reduced prior to the development of type 2 diabetes, even after adjusting for measures of obesity, and that administration of adiponectin has been accompanied by increased insulin sensitivity [38, 39].